Sunshine Biopharma (SBFM) Institutional Ownership → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free SBFM Stock Alerts $0.93 +0.04 (+4.49%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Sunshine Biopharma (NASDAQ:SBFM)CurrentInstitutional OwnershipPercentage41.98%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$31.39MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$39.04M Get SBFM Insider Trade Alerts Want to know when executives and insiders are buying or selling Sunshine Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… Sunshine Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024 Armistice Capital LLC2,130,000$578K0.0%+118.7%8.294% 11/15/2023 Armistice Capital LLC974,000$312K0.0%-55.6%3.793% 5/17/2022Empery Asset Management LP450,450$1.10M5.2%N/A2.730% (Data available from 1/1/2016 forward) SBFM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SBFM shares? During the previous two years, the following institutional investors and hedge funds held shares of Sunshine Biopharma shares: Armistice Capital LLC ($578K).Learn more on SBFM's institutional investors. What percentage of Sunshine Biopharma stock is owned by institutional investors? 41.98% of Sunshine Biopharma stock is owned by institutional investors. Learn more on SBFM's institutional investor holdings. Which institutional investors have been buying Sunshine Biopharma stock? The following institutional investors have purchased Sunshine Biopharma stock in the last 24 months: Armistice Capital LLC ($1.16M). How much institutional buying is happening at Sunshine Biopharma? Institutional investors have bought a total of 1,156,000 shares in the last 24 months. This purchase volume represents approximately $31.39M in transactions. Which Sunshine Biopharma major shareholders have been selling company stock? The following institutional investors have sold Sunshine Biopharma stock in the last 24 months: Armistice Capital LLC ($1.22M). How much institutional selling is happening at Sunshine Biopharma? Institutional investors have sold a total of 1,220,000 shares in the last 24 months. This volume of shares sold represents approximately $39.04M in transactions. Related Companies: EVLO Institutional Ownership BLPH Institutional Ownership LSDI Institutional Ownership ADTX Institutional Ownership NBSE Institutional Ownership APVO Institutional Ownership ATHX Institutional Ownership PBLA Institutional Ownership INM Institutional Ownership ATNF Institutional Ownership This page (NASDAQ:SBFM) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMost important medical advance in 100 yearsThe Oxford ClubDems have chosen Biden replacement?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.